Published : 27 Mar 2023
Paytm launches upgraded payments platform powered by 100% indigenous technology.
US FDA has issued Form 483 with 2 minor procedural observations for Alembic Pharma's Injectable & Ophthalmic facility (F-3), Karkhadi.
RBI imposes monetary penalty of Rs 3 mn on Karur Vysya Bank due to deficiencies in regulatory compliance.
Check More Details